Drug Trial Radar · NCT04531540
Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)
Last checked: Nov 19, 2026Latest source record: Nov 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
225
Actual
Start
Sep 9, 2013
Primary completion
Oct 18, 2013
Study completion Oct 18, 2013
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Aug 28, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
In this study researcher want to learn more about possible skin reactions such after repeated application of an antifungal cream containing Trolamine. They are especially interested in skin irritations or allergic skin reactions. The study plans to enroll about 225 female or male participants with the age 18 - 79 years. The antifungal test cream will be applied on the back between the shoulder blades of the participants and covered by a special dressing patch. This will be repeated 3 times a week for the first 3 weeks of this study applying the cream on the same area of the back. At each visit the skin will be investigated for redness, dryness and other reactions. After a rest period of two weeks the test cream will be applied on the same skin area as before and on a second new skin area nearby. After 2 and 4 days the two skin areas will again be investigated for redness, dryness and other reactions.
Conditions
- Hypersensitivity
Interventions
Butenafine HCl 1% (BAY1896425)Drug
Approximately 0.2 g of cream containing butenafine HCl 1% were applied to the upper back skin.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Irritation Response Evaluation According to Erythema Scoring Scale During Induction Phase - All Enrolled SubjectsTime frame: After 4 weeks
- Allergic Reaction Evaluation According to Erythema Scoring Scale During Challenge Phase - All Enrolled SubjectsTime frame: After 6 weeks
- Irritation Response Evaluation According to Erythema Scoring Scale During Induction Phase - All Evaluable SubjectsTime frame: After 4 weeks
- Allergic Reaction Evaluation According to Erythema Scoring Scale During Challenge Phase - All Evaluable SubjectsTime frame: After 6 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Site not named
Fairfield, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.